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A B S T R A C T
Childhood developmental disorders and related problems such as learning disabilities and attention
deﬁcit hyperactivity disorder (ADHD) account for a growing burden on the family, education and health
care systems. Exposure to environmental chemicals such as bisphenol A (BPA) and phthalates may play a
role in the development of child behavioral problems. Using cross-sectional data from Cycle 1 of the
Canadian Health Measures Survey (CHMS), we examined the potential association between urinary
concentrations of BPA and various phthalate metabolites and child learning and behavioral problems,
considering important covariates such as gender, blood lead and environmental tobacco smoke (ETS). The
Strengths and Difﬁculties Questionnaire (SDQ) outcomes of interest were emotional symptoms,
hyperactivity/inattention, and a total difﬁculties score with borderline and abnormal scores grouped
together and compared with children with normal scores. Other outcomes studied included any reported
learning disability, a subset of learning disabilities reported as ADD/ADHD (attention deﬁcit disorder) and
use of psychotropic medications in the past month.
Among children ages 6–11 years, the prevalences of any learning disability, ADD, and ADHD were 8.7%,
1.5% and 2.8%, respectively. Estimated prevalences for SDQ hyperactivity/inattention, emotional
symptoms and total difﬁculties scores were 16.9%, 15.0%, and 13.0%, respectively.
Child’s urinary BPA was associated with taking psychotropic medications (OR 1.59; 95% CI 1.05–2.40).
Urinary MBzP concentration was signiﬁcantly associated with emotional symptoms in girls (OR 1.38 95%
CI 1.09–1.75) but not in boys (OR 1.05 95% CI 0.82–1.36).) Blood lead was signiﬁcantly associated with
several of the outcomes examined, with a signiﬁcant interaction observed between prenatal smoking and
blood lead for the total difﬁculties score (OR = 10.57; 95% CI 2.81–39.69 vs. OR = 1.98; 95% CI 1.41–2.79 if
mother did not smoke during pregnancy).
Although limited by the cross-sectional nature of the study which precludes examining causation, the
results suggest that although some indicators of child behavior were signiﬁcantly associated with their
urinary BPA and phthalate concentrations, the major chemical associated with adverse behavioral
indicators was lead.
Crown Copyright ã 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
NeuroToxicology1. Introduction
Childhood developmental disorders and related problems such
as learning disabilities and attention deﬁcit hyperactivity disorder
(ADHD) account for a growing burden on the family, and the
education and health care systems. Children with these problems
may be at increased risk for antisocial behavior, lower educational
attainment, criminality and drug abuse later in life (Kessler et al.,* Corresponding author.
E-mail address: tye.arbuckle@hc-sc.gc.ca (T.E. Arbuckle).
http://dx.doi.org/10.1016/j.neuro.2016.03.014
0161-813X/Crown Copyright ã 2016 Published by Elsevier Inc. This is an open access arti
4.0/).1995; Copeland et al., 2013, 2007; Levy et al., 2014; Dalsgaard et al.,
2013).
In 2006, a disability related to learning affected 3.2% of all
children aged 5–14 in Canada (Statistics Canada, 2008). Approxi-
mately 1 in 6 children in the United States (2006–2008) reportedly
had a developmental disability ranging from mild to serious (Boyle
et al., 2011), highlighting the signiﬁcant public health and
economic impact on society and the family. The prevalence of
learning disabilities, ADHD and other development delays in the
US was 7.66%, 6.69% and 3.65%, respectively, with signiﬁcant
increases in rates over the past 12 years (Boyle et al., 2011).
The etiology of developmental disorders such as ADHD is
multifactorial, which underlies the importance of studying bothcle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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et al., 2008). The potential role of exposure to environmental
chemicals on the risk of developing child behavioral problems has
been investigated in numerous studies of pre-, post-natal and
concurrent exposures. As the brains of young children are
inimitably sensitive to environmental chemicals at levels signiﬁ-
cantly lower than those harmful to adults (Winneke, 2011), it is
critical to examine risks associated with ubiquitous emerging
chemicals. A recent expert panel has concluded that exposures in
Europe to endocrine disrupting chemicals contribute substantially
to neurobehavioral deﬁcits and disease, with estimated costs
of > s150 billion/year (Bellanger et al., 2015).
Lead is the most frequently studied environmental chemical,
with a recent meta-analysis supporting the association between
lead exposure and hyperactivity/impulsivity symptoms (Goodlad
et al., 2013). Prenatal exposure to tobacco smoke has also been
associated with a number of adverse outcomes most signiﬁcantly
and consistently being increased risk of behavioral disorders such
as ADHD (Abbott and Winzer-Serhan, 2012). As McCrory and Layte
(2012) have argued, prenatal tobacco smoke exposure may
increase risk for childhood behavioral problems through a number
of pathways, such as direct effects on brain biochemistry or
indirectly by increasing susceptibility to other risks; however, it is
also possible that the ﬁndings result from failure to adequately
account for important confounders (McCrory and Layte, 2012; Roza
et al., 2009; Lavigne et al., 2011).
Recently, there is concern that exposure to chemicals (such as
phthalates and bisphenol A (BPA)) in consumer products may be
associated with risks for developmental disabilities. There are a
number of different phthalates found in consumer products
ranging from fragrances to adhesives, polyvinyl chloride (PVC)
ﬂooring and food packaging. For example, diethyl phthalate is a
low molecular weight phthalate commonly used in cosmetics,
while di-(2-ethylhexyl) phthalate has a high molecular weight and
is commonly used as a plasticizer in PVC. BPA has been widely used
in polycarbonate consumer products, including reusable water
bottles and is also found in epoxy resins, which act as a protective
lining on the inside of metal-based food and beverage cans
(Government of Canada, http://www.chemicalsubstanceschimi-
ques.gc.ca/challenge-deﬁ/batch-lot-2/bisphenol-a/index-eng.php,
accessed 05.01.15).
Several studies have previously examined the potential
association between phthalates and BPA and developmental
disabilities in children. A strong positive association has been
observed between child urinary concentrations of metabolites
of di-(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate
(DnBP) and symptoms of ADHD (Kim et al., 2009). Urinary BPA
has been positively associated with total problems score and
negatively with learning quotient in school-age children (Hong
et al., 2013). Both phthalates and BPA are considered endocrine
modulating chemicals: phthalates are considered to function as
anti-androgens, while BPA may act as an estrogen (Weiss,
2012).
The evidence to date suggests that early life exposure to
environmental chemicals may be contributing factors in the
development of child learning and behavioral disabilities. The
major goal of this study was to explore the possible relation-
ships between concurrent exposure to BPA or phthalates and
several indicators of behavioral or learning difﬁculties in
children. A secondary question was to consider whether any
exposure risk remains signiﬁcant or interacts with lead or
passive tobacco exposure in a large population of children,
which has rarely been done previously, thus addressing an
important knowledge gap.2. Methodology
2.1. Study population and data collected
The Canadian Health Measures Survey (CHMS) was designed to
collect key information on the health of Canadians using direct
physical measurements, collection of blood and urine and
household and clinic interviews (Health Canada, 2010; Statistics
Canada, 2011). The target population for Cycle 1 were individuals
between 6 and 79 years of age living in privately occupied
dwellings, representing 97% of Canadians. This analysis focused on
children 6–11 years of age (n = 1080). Methods and results for
children 6–19 years of age combined are presented elsewhere
(Arbuckle et al., submitted). Information on child behavior,
demographic, socioeconomic and lifestyle factors was collected
by a questionnaire administered to the parent or guardian of these
children.
2.2. Exposure assessment
Mid-stream urine and whole blood were collected, frozen and
shipped to the Institut National de Santé Publique du Québec
(http://www.inspq.qc.ca/ctqenglish/home) for analyses. Details on
the lab’s quality control and quality assurance measures and
analytical methods are reported elsewhere (Health Canada, 2010).
Blood was analysed for lead (limit of detection [LOD] 0.02 mg/dL),
while urine was analysed for BPA (LOD 0.2 mg/L), cotinine (LOD
1.1 mg/L) and metabolites of di-n-butyl phthalate (mono-n-butyl
phthalate [MBP] LOD 0.2 mg/L), diethyl phthalate (mono-ethyl
phthalate [MEP] LOD 0.5 mg/L), dimethyl phthalate (mono-methyl
phthalate [MMP] LOD 5 mg/L), butyl benzyl phthalate (mono-
benzyl phthalate [MBzP] LOD 0.2 mg/L), di-cyclo-hexyl phthalate
(mono-cyclo-hexyl phthalate [MCHP] LOD 0.2 mg/L), di-iso-nonyl
phthalate (mono-isononyl phthalate [MNP] LOD 0.4 mg/L), di-n-
octyl phthalate (mono-n-octyl phthalate [MOP LOD 0.7 mg/L],
mono-(3-carboxypropyl) phthalate [MCPP] LOD 0.2 mg/L), and di-
(2-ethylhexyl) phthalate (mono-(2-ethylhexyl) phthalate [MEHP]
LOD 0.2 mg/L, mono-(2-ethyl-5-oxo-hexyl) phthalate [MEOHP]
LOD 0.2 mg/L, mono-(2-ethyl-5-hydroxy-hexyl) phthalate
[MEHHP] LOD 0.4 mg/L) using standardized methods (described
in Arbuckle et al., 2014). Creatinine was measured to adjust for
urine dilution using the colorimetric end-point Jaffe method. Any
lab results below the limit of detection were imputed as half the
limit of detection.
The administered questionnaire collected information on the
child’s current and prenatal exposure to environmental tobacco
smoke (ETS).
2.3. Childhood behavior and development
The Strengths and Difﬁculties Questionnaire (SDQ) (www.
sdqinfo.com) is a broad-band child mental health assessment tool
that has been used in epidemiologic studies to screen for attention-
deﬁcit/hyperactivity disorder (ADHD) as well as other behavioral
and emotional problems. The SDQ is highly correlated with other
instruments such as the Child Behavior Checklist (Goodman and
Scott, 1999).
The SDQ outcomes of interest for the multivariate analysis were
emotional symptoms, hyperactivity/inattention, and the total
difﬁculties score. Each sub-scale has validated cut-points where
possible values for the SDQ variables are normal, borderline and
abnormal. For the purposes of this analysis and to produce more
reliable results in the multivariate models given the sample sizes,
children with borderline and abnormal scores were grouped
together and compared with children with normal scores for each
of the scales and for the total difﬁculties scale.
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disability, and if yes, the type of learning disability: ADD or ADHD,
dyslexia, or another type of learning disorder. Given the limited
sample size, only any learning disability as well as ADD and ADHD
combined were considered further. We also considered whether
any medications used to treat behavioral disorders were taken in
the past month. Respondents reported medications by Drug
Identiﬁcation Numbers (http://www.hc-sc.gc.ca/dhp-mps/prod-
pharma/activit/fs-ﬁ/dinfs_fd-eng.php) which were coded to Ana-
tomical Therapeutic Chemical (ATC) codes (http://www.whocc.no/
atc_ddd_index/). One of the co-authors (KB), a clinical child
psychiatrist, provided a Table of medications potentially used for
treating behavioral disorders in children (see Supplemental
material, Table S1)
2.4. Statistical analysis
Initially, for each outcome of interest, univariate models were
considered for each contaminant. Covariates identiﬁed through
reviews of the literature included child’s age, body mass index,
number of hours slept per night, gender, highest level of household
education (secondary school or less vs. at least some postsecond-
ary studies), income adequacy (low/lower middle vs. upper
middle/higher income), whether the child fasted prior to specimen
collection, ETS exposure in the home, prenatal smoking, birth any
time prior to due date (in response to the question: Was he born
before, after or on the due date?), admission to a special neonatal
unit or an intensive care unit prior to leaving hospital, and breast
feeding (less than 3 months vs. three months or longer), as well as
number of days in a neonatal unit, birth weight, and mother’s age
at birth. Based on preliminary modeling, lead was a signiﬁcant
covariate for most outcomes, and thus was included in models for
BPA and phthalates.
Variables deemed signiﬁcant at the 10% level in the univariate
analysis were included in the multiple logistic regression models
with the dichotomous outcomes as the dependent variable and
individual natural log-transformed urinary concentrations as a
predictor along with creatinine and lead. In order to determine
which of the available predictor variables resulted in the best ﬁt, a
stepwise procedure was implemented whereby covariates were
added to or removed from the model based on the relative
signiﬁcance and may or may not have remained in the model. For
urinary chemicals, creatinine concentration was included in all the
multiple regression models as a separate independent variable to
correct for variable dilutions among spot urine samples. This
approach allows the statistical signiﬁcance of other variables in theTable 1
Weighted proportion of individuals in the Canadian population with learning and SDQ
Age Group Outcome Samp
All Respondents (6–79 years of age) Learning disability 276 
ADD 77 
ADHD 64 
Taking psychotropic medications 361 
Children (6–11 years of age) Learning disability 94 
ADD 20 
ADHD 29 
Taking psychotropic medications 42 
SDQ Conduct problems 165 
SDQ Hyperactivity/inattention 182 
SDQ Emotional symptoms 166 
SDQ Peer relationship problems 147 
SDQ Pro-social behavior 26 
SDQ Total difﬁculties 128 
E, Warning that high sampling variability is associated with these estimates. Results shmodel to be independent of effects of creatinine concentration
(Barr et al., 2005).
Furthermore, since the CHMS employed a complex, multistage
survey design, survey weights were used in descriptive statistics
and statistical modeling to account for the unequal probabilities of
selection. Due to the complex sampling scheme of the CHMS Cycle
1, direct calculation of standard errors and conﬁdence intervals
were not possible. To that end, Statistics Canada (2011) provided
bootstrap weights in order to calculate standard errors, conﬁdence
intervals and coefﬁcients of variation for each estimate using the
bootstrap method.
Moreover, in a complex survey sampling design setting the
degrees of freedom for statistical analysis are not related to the
sample size; rather they are calculated based on the difference
between the primary sampling units (or clusters) and the number
of strata (Lohr, 2010). The CHMS Cycle 1 selected 15 primary
sampling collection sites from a total of four regional strata, hence
the degrees of freedom for statistical analysis is equal to (15–
4) = 11. As a result of this reduced degrees of freedom, the CHMS
Data User Guide (Statistics Canada, 2011) cautions to “avoid ﬁtting
models with a large number of coefﬁcients.”
In order to determine which of the available variables resulted
in the best ﬁt, a stepwise procedure was implemented. We
considered the natural-log transformed contaminant and creati-
nine as a priori variables in the model. The natural-log of the
contaminant concentrations was used since the contaminants
were lognormally distributed based on the Anderson-Darling test.
However since the complex survey design limited the number of
degrees of freedom to 11, we employed a stepwise selection
method to determine which covariates were most signiﬁcant to
improve the model ﬁt. The contaminant and creatinine concen-
trations were retained in the model, and then other covariates
were sequentially added to the model based on the smallest p-
value (i.e. the most signiﬁcant variables). This approach facilitated
the evaluation of demographic variables one-at-a-time with
respect to their p-value, conditional on other variables already
in the model. This approach also served to examine the effect of
multicollinearity, which could inﬂate standard errors and provide
misleading results. For some models, after examining the main
effects, sufﬁcient degrees of freedom were available to evaluate an
interaction term between highly signiﬁcant covariates.
Furthermore, to compare models, we chose the model with
signiﬁcant terms and with the lowest value of the Akaike
Information Criterion (AIC). We further assessed goodness of ﬁt
using the Hosmer-Lemeshow test. Model assumptions were also
assessed as part of the regression ﬁtting. Spearman correlations
were calculated among the continuous covariates to assess outcome scores, CHMS Cycle 1 (2007–2009).
le size Weighted Proportion (%) 95% Conﬁdence Interval for Proportion
3.64 2.97–4.31
0.98 0.77–1.2
0.75 E 0.36 E–1.15 E
6.98 5.83–8.13
8.66 6.71–10.61
1.48E 0.58E–2.38E
2.75E 0.82E–4.68E
3.65E 2.09E–5.21E
15.28 11.85–18.72
16.88 14.10–19.67
14.98 13.51–16.45
13.42 10.03–16.80
2.73E 1.10E–4.36E
13.01 10.31–15.71
ould be interpreted with caution. (16.6%  CV  33.3%).
Table 2
Weighted Pearson correlation coefﬁcients of SDQ outcome scores from CHMS Cycle 1 (2007–2009) for children 6–11 years.
SDQ Scale Conduct problems Emotional symptoms Hyperactivity/
inattention
Pro-social behavior Peer-relationship problems Total Difﬁculties
Conduct problems 1 0.2544 0.5831 0.4572 0.3397 0.7303
Emotional symptoms 1 0.3158 0.0739 0.3383 0.6420
Hyperactivity/inattention 1 0.3193 0.3804 0.8452
Pro-social behavior 1 0.2713 0.3779
Peer-relationship problems 1 0.6674
Total Difﬁculties 1
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tween covariates, separate models were ﬁt for each variable to
reduce the effects of multicollinearity. Important in the modeling
of survey data, we also assessed the informativeness of the
sampling design (Binder et al., 2005; Lohr, 2010).
The software package SAS (Statistical Analysis System) Enter-
prise Guide 4.2 was used for statistical analysis. For both
descriptive statistics and regression modeling, the software
programs BOOTVAR and SUDAAN were used along with the
bootstrap weights, in order to correctly calculate such estimates.
Finally, for all statistical analysis performed, an inference was
deemed signiﬁcant at a = 5% unless otherwise indicated.
3. Results
3.1. Prevalence of developmental difﬁculties
Table 1 provides the weighted proportion of individuals in the
Canadian population with developmental and behavioral out-
comes of interest. Based on parental reports, the prevalence of a
learning disability, ADD, and ADHD in children 6–11 years of ageTable 3
Comparison of Canadian and US statistics for environmental chemical concentrations in
2010) and NHANES (2007–2008) (CDC, 2014).
Chemical Age Survey N 
Bisphenol A (mg/L) 6–11 CHMS 103
NHANES 389
Cotinine (mg/L)a 6–11 CHMS 105
Phthalates (mg/L)
MBzP 6–11 CHMS 104
NHANES 389
MBP 6–11 CHMS 104
NHANES 389
MCHP 6–11 CHMS 104
NHANES 389
MEP 6–11 CHMS 104
NHANES 389
MEHP 6–11 CHMS 104
NHANES 389
MEHHP 6–11 CHMS 104
NHANES 389
MEOHP 6–11 CHMS 104
NHANES 389
MOP 6–11 CHMS 104
NHANES 389
MMP 6–11 CHMS 104
NHANES 389
MCPP 6–11 CHMS 104
NHANES 389
MNP 6–11 CHMS 104
NHANES 389
Lead (mg/dL) 6–11 CHMS 915
NHANES 101
GM: geometric mean; LOD: limit of detection; X: not calculated as proportion below de
these estimates. Results should be interpreted with caution. (16.6%  CV  33.3%); F: the
guidelines and are suppressed.
a NHANES measures serum rather than urinary cotinine concentrations.was 8.7%, 1.5% and 2.8%, respectively. The ADD/ADHD outcomes
represented about half of all the learning disabilities reported. In
the same age group, based on SDQ scores, the prevalence for
hyperactivity/inattention, emotional symptoms and total difﬁcul-
ties was 16.9%,15.0% and 13.0%, respectively. Most SDQ scores were
positively correlated with the exception of scores related to pro-
social behavior, which were negatively correlated with other SDQ
outcomes (Table 2). Sample sizes were too small to exclude
children taking psychotropic medications from analysis of the
other outcomes. There were many children who were treated with
psychotropic medications yet still had reported learning/SDQ
outcomes. For instance, considering the unweighted frequencies,
there were 49 children aged 6–11 who were reported as having
ADD/ADHD, of whom 29 were taking psychotropic medications
and 20 who were not.
3.2. Prevalence of environmental exposures
The weighted descriptive statistics for BPA, cotinine, phthalates
and lead are presented in Table 3 and compared with those from
the US NHANES (CDC, 2014). The geometric means for children 6– urine and lead in blood for children, CHMS Cycle 1 (2007–2009) (Health Canada,
% <LOD GM 95th Percentile
8 6.44E 1.31 7.24
 2.48 13.4
2 84.06 0.81 10.28
4 0.00 21.23 131.08
 15.4 131
4 0.00 33.11 167.19
 26.9 119
4 84.40 <LOD F
 X <LOD
4 F 26.06 210.64E
 49.0 296
4 0.00 3.33 17.76
 2.39 15.1
4 0.00 31.54 179.53
 28.6 242
4 0.00 19.99 106.66
 16.9 137
4 95.47 <LOD F
 X <LOD
4 66.12 <LOD 24.53
 X 12.1
4 2.66E 2.67 13.39
 6.01 23.9
3 99.16 <LOD <LOD
 X 2.16
 0.00 0.90 1.96
1 0.988 2.50
tection limit too high; E: Warning that high sampling variability is associated with
se estimates are of unacceptable quality, as determined by Statistics Canada release
Table 4
Weighted Descriptive Statistics for Socio-Demographic Covariates of Interest for Children Ages 6–11 years: CHMS Cycle 1 (2007–2009).
Variable n Arithmetic Mean 95% Conﬁdence Interval
Child's Age 1080 8.58 8.38 8.79
No. of hours slept 1080 9.68 9.57 9.79
Birth weight (g) 1045 3395.10 3337.30 3452.89
BMI 1078 17.80 17.55 18.04
Mother’s age at birth 1071 29.15 28.44 29.87
Variable n Percent 95% Conﬁdence Interval
Males 547 51.2% 51.0 51.4
Canadian-born 982 92.3% 86.0 98.5
Prenatal smoking (Yes) 163 17.1% 13.1 21.2
Smoking at home (Yes) 122 10.3% 7.4 13.3
Low birth weight (Yes) 66 5.7% 3.9 7.4
Special neonatal unit care (Yes) 153 12.8% 9.3 16.2
Born any time before due date (Yes) 440 41.8% 37.4 46.2
Breastfed > = 3 months 862 83.4% 79.7 87.1
Fasted (Yes) 556 50.3% 46.4 54.2
Household Income: Low/Low-middle 267 26.7% 20.0 33.4
Highest Level of Education: High School or less 134 13.0% 9.2 16.8
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and MEHHP, respectively and 0.9 mg/dL for lead. It was evident
that, for some contaminants, both unadjusted and creatinine-
adjusted BPA and phthalate urinary concentrations in the children
differed by age, gender and exposure to prenatal smoking (data not
shown). Regression modeling was used to further analyze these
differences while accounting for other demographic variables of
interest. Cotinine and the phthalates MCHP, MMP, MNP and MOP
were not considered further since more than 65% of the data fell
below the limit of detection, and statistical reliability was
questionable.
3.3. Descriptive statistics of covariates of interest
Table 4 provides summary statistics for covariates considered in
the analysis. We note that the average age of children in this study
was 8.58 years (95% CI 8.38–8.79) with average maternal age at
birth of 29.15 years (95% CI 28.4–29.9). Furthermore, 51.2% of the
children were males, while 92.3% were born in Canada. Further,
10.3% reported smoking at home (95% CI 7.4–13.3%) while 17.1%
reported prenatal smoking (95% CI 13.1–21.2%). We also note that
12.8% of children required neonatal unit care, 41.8% were born any
time prior to their due date and 83.4% of mothers breastfed for
more than 3 months.Table 5
Summary of Multiple Logistic Regression Results for Parent-Reported Outcomes from the
Contaminant ADD/ADHD 
OR (95% CI) 
BPA 1.31 (0.81–2.12) 
MBP 0.62 (0.34–1.15) 
MBzP 1.41 (0.94–2.13) 
MCPP 1.32 (0.69–2.51) 
MEHHP 0.72 (0.29–1.78) 
MEHP M: 0.96 (0.53–1.76)
F: 0.25 (0.11–0.57)a
MEOHP 0.66 (0.20–2.10) 
MEP 0.83 (0.44–1.57) 
Blood Lead 2.08 (1.01–4.25) 
M: males; F: females. Models adjusted for covariates as determined by a stepwise mul
a Interaction terms signiﬁcant at 5% level between contaminant and other covariates3.4. Multivariate analysis: environmental chemicals
Odds ratios calculated from weighted multiple logistic regres-
sion models are presented for the reported (Table 5) and the SDQ
(Table 6) identiﬁed outcomes. Models are presented in the
Supplemental materials.
Blood lead was statistically (p = 0.047) associated with reported
ADD/ADHD in the weighted multiple regression model. A 1-unit
increase in ln-blood lead increased the odds of ADD/ADHD by 2.08
(95% CI = 1.01–4.25), other variables held constant (Table 5 and
Supplemental material Table S2). The nature of the association
between ln-MEHP and ADD/ADHD depended on the child’s gender,
with increasing ln-MEHP associated with a signiﬁcantly lower risk
of ADD/ADHD in females (OR: 0.25; 95% CI 0.11–0.57).
None of the contaminants were signiﬁcantly associated with
reported learning disability (Supplemental material Table S3). BPA
and lead were signiﬁcantly associated with taking psychotropic
medication (ln-BPA: OR = 1.59; 95% CI 1.05–2.40 and ln-Lead:
OR = 2.91, 95% CI 1.47–5.79) (Table 5 and Supplemental material
Table S4).
In regards to the SDQ outcomes, the only contaminant
associated with the total difﬁculties score was lead and a
signiﬁcant interaction term between lead and prenatal smoking
(p = 0.029) was observed. Speciﬁcally, for each one unit increase in Canadian Health Measures Survey Cycle 1 (Weighted) for Children Aged 6–11 Years.
Any Learning Disability Psychotropic Medicine Taken
OR (95% CI) OR (95% CI)
1.31 (0.89–1.92) 1.59 (1.05–2.40)
0.94 (0.61–1.46) 0.63 (0.28–1.42)
1.57 (0.89–2.79) 0.92 (0.49–1.70)
1.30 (0.86–1.98) 1.28 (0.67–2.42)
0.84 (0.42–1.68) 1.08 (0.28–4.20)
0.88 (0.50–1.54) 1.02 (0.26–4.04)
0.84 (0.37–1.94) 1.05 (0.25–4.36)
1.00 (0.47–2.14) 1.41 (0.63–3.18)
1.41 (0.73–2.70) 2.91 (1.47–5.79)
tiple regression procedure (see Supplemental material).
.
Table 6
Summary of Multiple Regression Results for SDQ outcome scores from the Canadian Health Measures Survey Cycle 1 (Weighted) for Children Aged 6–11 Years.
Contaminant Total Difﬁculties Emotional Symptoms Hyperactivity/Inattention
OR (95% CI) OR (95% CI) OR (95% CI)
BPA 1.01 (0.73–1.41) 1.02 (0.85–1.23) 1.05 (0.84–1.30)
MBP PS: 2.34 (0.81–6.78)
NPS: 0.85 (0.73–1.00)
0.79 (0.58–1.08) 1.05 (0.64–1.74)
MBzP 1.26 (0.96–1.66) M: 1.05 (0.82–1.36)
F: 1.38 (1.09–1.75)a
1.05 (0.78–1.41)
MCPP 1.21 (0.77–1.89) 0.96 (0.78–1.19) 1.30 (1.00–1.70)
MEHHP 1.00 (0.60–1.65) 0.87 (0.59–1.29) 1.02 (0.61–1.70)
MEHP 1.11 (0.57–2.15) 0.86 (0.65–1.15) 0.96 (0.57–1.64)
MEOHP 0.99 (0.59–1.64) 0.86 (0.60–1.22) 0.96 (0.56–1.66)
MEP 1.16 (0.86–1.58) 1.05 (0.73–1.51) 1.12 (0.94–1.33)
Blood Lead PS: 10.57 (2.81–39.69)
NPS: 1.98 (1.41–2.79)a
1.25 (0.602.59) 2.75 (1.46–5.16)
PS: prenatal smoking; NPS: no prenatal smoking. Models adjusted for covariates as determined by a stepwise multiple regression procedure (see
Supplemental material).
a Interaction terms signiﬁcant at 5% level between contaminant and other covariates.
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difﬁculties score was higher if their mother smoked during
pregnancy than for children whose mother did not smoke (ln-lead:
prenatal smoking OR = 10.57; 95% CI 2.81–39.69 vs. no prenatal
smoking OR = 1.98; 95% CI 1.41–2.79) (Table 6 and Supplemental
material Table S7).
For the emotional symptoms score, only MBzP (p = 0.046) was
signiﬁcant and varied by gender. A higher odds ratio was noted for
females than males (ln-MBzP: females OR = 1.38; 95% CI
1.09–1.75 vs. males OR = 1.05, 95% CI 0.82–1.36). (Table 6 and
Supplemental material Table S5).
Weighted regression models showed that only blood lead was
signiﬁcantly associated (p = 0.005) with hyperactivity/inattention
SDQ outcome (Supplemental material Table S6). A one unit
increase in ln-lead was associated with an odds ratio of 2.75 (95% CI
1.46–5.16).
Prenatal smoking was a signiﬁcant factor for many outcomes,
including ADD/ADHD, presence of a learning disability, SDQ
hyperactivity/inattention and SDQ total difﬁculties (see Supple-
mental material tables).
3.5. Multivariate analysis: other covariates
In the course of analysis, other covariates not of primary
research interest were found to be signiﬁcant using weighted
multiple logistic regressions. Gender was signiﬁcantly associated
with many outcomes, with males generally at higher risk than
females. A notable exception was SDQ emotional symptoms, where
the odds ratio for females was higher than that for males
(Supplemental material Table S5).
Breastfeeding was signiﬁcant for some models of the outcome
SDQ hyperactivity/inattention (Supplemental material Table S6).
In several models, the interaction term between breastfeeding and
gender was signiﬁcant. For example, males breastfed for 3 or more
months had an odds ratio for hyperactivity/inattention of 0.35 (95%
CI = 0.19–0.65) compared to males who were breastfed less than
3 months. For females, breastfeeding did not signiﬁcantly impact
the odds of hyperactivity/inattention (OR = 1.14, 95% CI = 0.65–
2.02).
The number of hours slept per night had a negative and
signiﬁcant association with the presence of a learning disability,
SDQ emotional symptoms, SDQ hyperactivity/inattention, and SDQ
total difﬁculties. As an example, one additional hour of sleep for 6–
11 year old children was associated with a decrease in the odds of a
total difﬁculty problem by 0.54 (95% CI = 0.37–0.78) (Supplemental
material Table S7).Further, the child’s age was signiﬁcantly and positively
associated with reported learning disability (Supplemental mate-
rial Table S3).
Finally, birth any time prior to due date was signiﬁcantly
associated with reported ADD/ADHD, taking psychotropic medi-
cations, SDQ emotional symptoms, and SDQ total difﬁculties
(Supplemental material). For instance, the odds of having a total
difﬁculties score was 2.11 times higher for a child born prior to due
date versus a birth at or after the due date (95% CI = 1.10–4.03),
other variables held constant (Supplemental material Table S7).
In terms of model ﬁt, some of the weighted models presented
exhibited minor lack of ﬁt, in that results of the Hosmer-Lemeshow
test often exhibited p-values near 0.10, and some large residuals
were noted. Transformations were considered, such as higher-
order terms (quadratic, cubic, etc.) to consider nonlinear relation-
ships and improve model ﬁt; however, only slight improvements
were noted. Unfortunately other remedial measures could not be
considered since the CHMS sample design prescribed only 11
degrees of freedom for hypothesis testing; hence additional
variables could not be included and tested within the model.
4. Discussion
Recent reviews have shown that environmental chemicals may
play a role in the etiology of behavioral and developmental
disorders (Grandjean and Landrigan, 2014; Rochester, 2013;
Jurewicz et al., 2013; Braun et al., 2013). In our study, the results
indicated that environmental chemicals such as lead and to a lesser
extent BPA and some phthalates may be associated with behavioral
problems among Canadian children.
We found that lead was the environmental chemical most often
associated with a variety of non-internalizing behavioral out-
comes, even after controlling for variables such as smoking, gender,
breastfeeding and household income. There was some internal
consistency in the results in that lead was associated with
increased risks of ADD/ADHD, taking psychotropic medications,
as well as SDQ hyperactivity/inattention and total difﬁculties
scores. We found a signiﬁcant interaction between child blood lead
and prenatal ETS exposure for the total difﬁculties score (OR 10.57;
95% CI 2.81–39.69); although the conﬁdence interval was large and
only seventeen percent of the children were prenatally exposed to
ETS. Froehlich et al. (2009) also found that children with both
prenatal ETS and 3rd tercile blood lead levels (>1.3 mg/dL) had an
OR of 8.1 (95% CI 3.5–18.7) for ADHD. Higher blood lead
concentration in children has been associated with conduct
disorders in the US NHANES (Braun et al., 2008), as well as
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2015) even after adjusting for multiple confounding variables.
Although blood lead concentrations have decreased over the past
decades, new research on lead has demonstrated that its toxicity
has not disappeared and that a threshold level below which lead
can be considered “safe” has yet to be identiﬁed (Bellinger, 2011). It
has been estimated that the impact of lead exposure on Full-Scale
IQ (FSIQ) scores of children less than 5 years of age is a loss of
23,000,000 points, compared to a loss of 34,000,000 FSIQ points
for a major non-chemical risk factor such as preterm birth
(Bellinger, 2012). Decreasing lead exposure in children must
continue to be a major public health priority, and in particular for
the reduction of risk for behavioural difﬁculties in children.
We found that exposure to BPA was associated with taking
medications for behavioral problems in boys and girls, but not
behavioural or emotional problems, themselves. However, in
another cross-sectional study of child exposure to BPA and
behavior that also adjusted for phthalates and lead exposure,
urinary BPA was positively associated with the Child Behavior
Checklist (CBCL) Total Problems score (Hong et al., 2013). BPA
concentrations appeared to be similar in the two surveys.
Considering studies which have sampled children in the same
age range used in our analysis, higher post-natal BPA was
associated with increased behaviors on both the CBCL internaliz-
ing, composite, and externalizing composite scores and individual
subscores in girls only (Roen et al., 2015), or boys only (Harley et al.,
2013) with conduct symptoms being the only symptom for
exposure in girls (Harley et al., 2013).
Although there is some inconsistency in the literature which
might be related to the use of different tools to assess children’s
behavior, it appears that the timing of exposure to BPA may have a
signiﬁcant impact on gender differences in the relationship
between BPA and neurobehavioral functions. While the two
cross-sectional studies (current study; Hong et al., 2013) did not
report any gender-dependent effects for BPA, two cohort studies of
post-natal exposure found associations predominantly in girls
(Harley et al., 2013; Roen et al., 2015). In contrast, prenatal
exposure to BPA was associated with increased behavioral
problems in boys in most of the studies (Perera et al., 2012; Evans
et al., 2014; Harley et al., 2013; Roen et al., 2015), with one
exception where more adverse effects were observed in girls
(Braun et al., 2009, 2011). A recent review has also reported
stronger associations between prenatal vs. childhood exposure to
BPA and adverse behavioral effects in six out of seven studies
examined (Mustieles et al., 2015).
The animal literature suggests that exposure to BPA affects the
development of the forebrain dopaminergic system via binding to
estrogen dependent dopaminergic receptors that are important for
regulation of behavioral impulses (Narita et al., 2006; Suzuki et al.,
2003). Forebrain regions are also important for controlling
emotional regulation and reactivity, a neurobehavioral function
that may be measured in the rating scales various studies have
used. Prior to puberty, the risk for most behavioural outcomes and
in some cases emotional outcomes is greater for boys. This risk may
be related to relative immaturity of the forebrain regions in boys
(Neufang et al., 2009). The apparent endocrine proﬁle produced by
BPA is an elevation of serum T4 despite normal TSH levels and an
apparent overstimulation of the TRa receptor (Zoeller, 2006). This
proﬁle is similar to that in humans caused by a mutation in the TRb
receptor with the subsequent thyroid resistance syndrome
(Refetoff et al., 1994) which was found to be associated with a
number of symptoms including attention deﬁcit disorders (Cheng,
2005; Togashi et al., 2005). BPA exposure also induces prefrontal
and hippocampal spine synapse loss in rodents which may result in
cognitive dysfunction and developmental depressive behavior
(Hajszan and Leranth, 2010). A key ﬁnding across a range ofdevelopmental toxicity studies is that BPA has shown effects on
sex-differentiation of exploratory and affective behavior at lower
doses (Golub et al., 2010). There is also some evidence to suggest
that BPA can result in changes in structural development of the
brain, disruption of estrogen regulation at a number of levels,
alterations in DNA methylation of the genome, and affect social
behavior, anxiety and maternal behavior (Wolstenholme et al.,
2011). Thus, BPA is associated with behavioral syndromes in rats in
laboratory conditions possibly as the result of BPA interference
with hormonal and genomic regulation and brain neurogenesis.
Whether these effects occur in humans at typical environmental
exposure levels is unknown, although if they occur, it is likely that
the effects are sex dependent in their expression given the
observed sex differences in developmental brain physiology that
have been reported.
Among the phthalate metabolites, MCPP was associated with
higher odds of SDQ hyperactivity/inattention (1.30, 95% CI 1.00–
1.70). In contrast, an analysis of the US NHANES data for children 6–
15 years of age reported no signiﬁcant association of MCPP with
learning difﬁculties or ADD (Chopra et al., 2014). It should be noted
that MCPP is a non-speciﬁc metabolite of multiple parent
phthalates.
MBzP was associated with higher odds of SDQ emotional
symptoms in girls, but no other outcomes. In a cross-sectional
analysis in the US, MBzP was also not associated with ADD or a
learning disability (Chopra et al., 2014). However, two studies of
prenatal exposure to MBzP have reported associations with
internalizing behaviors in girls (Whyatt et al., 2012; Kobrosly
et al., 2014). MBzP is the major metabolite of benzylbutyl
phthalate, which is used in Canada as a plasticizer in polyvinyl
chloride (PVC) ﬂooring and other materials, in paints and coatings,
in adhesive formulations and in printing inks (Health Canada and
Environment Canada, 2000).
Our observations that increasing urinary concentrations of
MEHP (a DEHP metabolite) in children 6–11 years of age was
associated with a signiﬁcantly decreased risk of ADD/ADHD and
was not associated with SDQ hyperactivity/inattention are not
consistent with previous studies which in general report an
increased risk of ADHD symptoms (Kim et al., 2009; Park et al.,
2015). However, an analysis of US NHANES (2001–2004) for
children 6–15 years of age reported an increased odds of parent-
reported ADD with increasing urinary DEHP and high molecular
weight phthalates, with stronger associations observed in girls
than boys (Chopra et al., 2014). A recent systematic review further
suggested that elevated prenatal exposure to phthalate metabo-
lites was also associated with poorer cognitive and behavioral
outcomes in children less than 12 years of age with gender-speciﬁc
differences observed, but also identiﬁed a number of inconsisten-
cies in the literature (Ejaredar et al., 2015). A number of factors may
explain the inconsistencies among these studies: the diverse
cognitive and behavioral functions assessed as well as the use of
different tools to measure these functions, different levels of
exposure among the studies, the potential exposure misclassiﬁca-
tion introduced by using a single urine void to measure exposure
(Fisher et al., 2015), varying mixtures of phthalates, the timing of
the exposure measure, and the genetic make-up of the popula-
tions, as well as other unknown factors.
Based on the results of studies of prenatal exposure to
phthalates and poor performance on neurodevelopmental test
scores, the Chronic Hazard Advisory Panel on Phthalates and
Phthalate Alternatives has recommended that human exposure to
DEHP, DBP and DEP should be reduced (US Consumer Product
Safety Commission, 2014).
As with BPA, the biological mechanisms underlying any
potential associations between phthalates and child behavior
are still to be determined. There are published reports of
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Thyroid hormones play a critical role in fetal and child growth and
brain development (Diamanti-Kandarakis et al., 2009). In a cross-
sectional analysis of NHANES data, inverse relationships between
urinary metabolites of DEHP and total T4 levels were observed in
adult participants (Meeker and Ferguson, 2011). In contrast, in
participants 12–19 years, there was evidence of a positive
relationship between DEHP metabolites and T3 and TSH. However,
a Danish study of children 4–9 years reported an inverse
relationship between DEHP metabolites and free and total T3
(Boas et al., 2010). A small study (n = 76) of pregnant women
reported a signiﬁcant inverse association between urinary MnBP
and serum levels of free and total T4 (Huang et al., 2007). As the
correlations between phthalate exposure and thyroid indicators
are different, although not necessarily inconsistent across these
differently aged populations, the impact of phthalates on thyroid
function is likely to be developmental and requires further
investigation.
Consistent with previous research, prenatal but not post-natal
exposure to tobacco was signiﬁcantly associated with various child
behavioral outcomes in this analysis. Prenatal ETS exposure has
been more consistently predictive of ADHD than postnatal
exposures (Braun et al., 2006).
Our results showed that the number of hours slept per night
was negatively associated with whether psychotropic medications
were taken and various SDQ scales. Child sleep problems are a
prominent clinical comorbidity with ADHD (Owens et al., 2013)
and signiﬁcantly associated with poorer academic, behavioral and
social functioning (Becker, 2014).
Given that being born any time before anticipated due date was
such an important developmental factor associated with psycho-
pathology/behavioral problems in our analysis of children 6–
11 years of age, we recommend that this factor be considered in
multivariate models in future research to examine risk factors for
these outcomes.
5. Strengths and limitations
A strength of this exploratory analysis is that, as the CHMS is a
large biomonitoring survey representative of the Canadian
population, we were able to generalize these results, using
weighted estimates, to the Canadian population 6–11 years of
age. In addition, we were able to consider statistical interactions
with a number of critical factors including co-exposure to lead.
There are a number of limitations to this analysis that preclude
any conclusions about etiology; key amongst these is the cross-
sectional nature, which does not allow a time interval between
exposure and disease onset. Therefore, it is also possible that
children experiencing adverse behaviors such as ADHD are at
higher risk of greater exposure to environmental lead (Goodlad
et al., 2013) and possibly other chemicals.
There were several important potential risk factors that we
could not include in our analyses such as measures of maternal
nutrition and mental health. A recent study reported that higher
maternal circulating levels of 25(OH)D3 in pregnancy were
associated with lower risk of developing ADHD-like symptoms
in childhood (Morales et al., 2015). We also could not adjust for a
set of robust contextual and biological confounding variables to
children’s learning and behavioral outcomes, namely parental
learning and behavioral indicators. Approximately 75% of the
etiologic processes contributing to ADHD are genetic in origin
(Biederman and Faraone, 2005) while the heritability of other
psychiatric disorders is also substantial (between 30 and 60% on
average). Further, we could not control for factors that might affect
the reported outcomes such as the child’s family relationshipsincluding experience of abuse, neglect, or witnessing violence in
the home.
A major limitation of this analysis is the likely exposure
misclassiﬁcation bias due to the short elimination half-life of BPA
and phthalates. There can be considerable intra-individual
variability in urinary concentrations of BPA (Heffernan et al.,
2014) and phthalates (Teitelbaum et al., 2008; Watkins et al., 2014)
in children. In pregnant women, BPA and phthalates measured in
urine have shown considerable variability within a day and across
days, with low sensitivity to correctly classify a single sample as
high or low exposure (Fisher et al., 2015). Depending on the sources
of exposure, when the urine was collected can also have a
signiﬁcant impact on the urinary concentration measured.
Children are exposed to combinations of chemicals that may
exert additive, synergistic or antagonistic effects on neurodevel-
opment. Our limited sample size did not permit examination of
mixtures of a broad range of potential neurotoxicants.
Some of the estimated rates of the outcomes studied were
subject to high sampling variability (Table 1) and therefore these
results should be interpreted with caution. Furthermore, the
outcomes of interest were based on answers to survey questions by
respondents and may be subject to reporting bias. Recall bias may
also occur as parents may not remember certain details
surrounding their habits during a pregnancy that occurred several
years ago, or may fail to report exposure to certain factors such as
prenatal smoking or breastfeeding, due to social stigma.
As multiple analyses were conducted, signiﬁcant results may
have been found by chance. Finally, contaminant levels which were
below the laboratory’s limit of detection, i.e. non-detects, were
substituted by half of the value of the limit of detection, prior to
statistical analysis. Recent research has indicated that in the
unweighted setting, such substitution may lead to biased and
inefﬁcient estimates, compared to other techniques such as
maximum likelihood methods (Helsel, 2012). However, little
research is available on analysis of complex survey data in the
presence of non-detects, thus future work which would extend
such models to design-based estimates would be advantageous.
6. Conclusions
Our ﬁndings on postnatal exposures and emotional and
behavioural outcomes in children are generally consistent with
the existing literature; however, some differences are notable such
as the absence of an association between DEHP phthalate
metabolites and ADHD or behavioural outcomes that has been
observed in other studies (Kim et al., 2009; Testa et al., 2012;
Chopra et al., 2014; Park et al., 2015). In fact, we observed a
signiﬁcantly lower risk of ADD/ADHD in girls with increasing
MEHP levels. We also observed an association between MCPP and
ADHD which has not been previously reported. The association
between BPA and prescriptions for behaviour disorders suggests an
association between BPA and behaviour disorders or attention
problems as supported robustly in the literature even though the
measure is indirect.
There are also important sex differences in the strength and
direction of the associations between chemical exposures and
behavioural or emotional outcomes in children, but we only
demonstrated the increased risk of emotional symptom in girls in
association with MBzP. The absence of replication of others’
ﬁndings of sex differences may be because of the reduced number
of items the SDQ contains to measure these domains compared to
more commonly used measures (CBCL) in other studies. Sex
differences in ADHD would be difﬁcult to detect as ADHD in girls is
typically under-identiﬁed in studies where parent and teacher self-
report measures are used (Quinn, 2008).
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and behavioural problems, and aspects of their distinct etiological
processes, it is important to recognize that there is signiﬁcant
common variance amongst these domains. Comorbidity and
correlation is common (average correlation estimate at 0.4)
(Krueger et al., 2001). The ﬁnding of speciﬁcity of exposures to
one versus the other outcome is important and suggests important
differences in mechanisms by which environmental chemicals
affect the development of psychological symptoms. Indeed, further
characterization and measurement of processes such as thyroid
metabolism and brain imaging in relation to environmental
exposures at different developmental stages will help establish
the mechanism of risk relevant to such exposure.
In conclusion, our results indicated that environmental
chemicals such as lead and prenatal exposure to environmental
tobacco smoke were associated with learning disabilities and
behavioral problems. Lead was signiﬁcantly associated with
reported ADD/ADHD and SDQ hyperactivity/inattention and total
difﬁculties. Furthermore, the association between lead and SDQ
total difﬁculties was signiﬁcantly increased in children who were
prenatally exposed to tobacco. To a lesser extent, BPA and a few
phthalates were associated with some behavioral outcomes;
however it is unlikely that having only a single concurrent and
unreliable measure of these chemicals captured the pertinent
exposures for chronic conditions such as ADHD. The child’s gender,
age, hours of sleep, birth any time prior to due date, stay in a special
neonatal unit after birth, breastfeeding and prenatal exposure to
ETS were often important covariates in the various models.
While the study did examine multiple environmental risk
factors, the cross-sectional nature of the study limited our ability to
conclude that exposure to environmental chemicals was causally
linked with adverse child behaviors. These ﬁndings underscore the
need for prospective cohort studies measuring different combi-
nations of environmental chemicals in concert with key child
neurodevelopmental risk factors for such outcomes to better
elucidate the etiology of ADHD and other child learning and
behavioral problems. Future studies of non-persistent chemicals
such as BPA need to develop more accurate measures of exposure.
Given the high costs of collecting and analysing multiple samples
per individual, research should focus on developing statistical
models that take into account predictors of urinary concentrations
such as time of day, time since last void, weekday vs weekend,
intra-class correlation coefﬁcients for the time period of interest
and hydration status (Arbuckle et al., 2015; Fisher et al., 2015).
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